The inhibition of PAK1 or PAK4 suppresses pancreatic cancer by stimulating anti-tumour immunity through the activation of T cells and dendritic cells through ICAM-1 and VCAM-1 upregulations [15]. Here, PAK4 is linked to familial pancreatic carcinoma.